MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Quantum-Si Stock

Quantum-Si incorporated

QSINASDAQMarkt
US$1.12
-14.5% today

Company data

Sector
Healthcare
Industry
Medical - Devices
Country
United States
CEO
Jeffrey Alan Hawkins
Employees
145
Market cap
$223 M
IPO
13/11/2020

Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule…

Quantum-Si stock: price history

16/10/25-55.9 %16/10/26

1D

-14.5%

1W

-26.8%

1M

+53.4%

6M

+4.7%

YTD

+1.8%

1Y

-55.9%

2Y

+37.2%

5Y

-87.0%

10Y

–

Next earnings date

Next earnings date

04/11/2026 (in 18 days)

Volatility around earnings

~1% stronger price swings than usual

Ask the agents about Quantum-Si

Analyst assessment of Quantum-Si

PRICE TARGET LOW

US$1.90

CONSENSUS

US$2.95

MEDIAN

US$2.95

PRICE TARGET HIGH

US$4.00

0

STRONG BUY

1

BUY

1

HOLD

0

SELL

0

STRONG SELL

2

TOTAL · Buy

As of: 29/09/2026

ANALYST FIRMRATINGACTIONDATE
HC Wainwright & Co.Buymaintain29/09/2026
Canaccord GenuityHoldmaintain05/03/2026
Canaccord GenuityHoldmaintain22/12/2025
Canaccord GenuityHoldmaintain27/10/2025
Canaccord GenuityHoldmaintain09/09/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain19/05/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain14/01/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain21/11/2024 (older than 12 months)

Quantum-Si stock metrics

P/E

-2.41

P/B

1.35

EV/EBITDA

-2.23

RETURN ON EQUITY

-13.1%

NET MARGIN

-6,841.3%

DEBT/EQUITY

0.02

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

86.1%

FLOAT SHARES

171,250,528

AVG. DAILY VOLUME (30D)

7,842,521

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

LaPointe Christian

OfficerSale9,7950.76Spontaneous23/09/2026

LaPointe Christian

OfficerSale4,7210.76Spontaneous23/09/2026

Keyes Jeffry R.

OfficerSale5,1720.76Spontaneous23/09/2026

Keyes Jeffry R.

OfficerSale2,4930.76Spontaneous23/09/2026

Hawkins Jeffrey Alan

OfficerSale20,1430.76Spontaneous23/09/2026
Page 1 / 3

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: -14.5%

Forums (Reddit)

06/1009/1012/10

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
ANCHYRA PARTNERS LLC0-18,97430/09/2026
True Wealth Design, LLC0-72030/09/2026
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC0-63,43530/09/2026
Essential Partners LLC0-3,09430/09/2026
GILL CAPITAL PARTNERS, LLC0-20030/09/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Quantum-Si stock

What does Quantum-Si do?

Quantum-Si incorporated is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.

The CEO is Jeffrey Alan Hawkins, the company employs around 145 people.

The IPO was on 13/11/2020; the stock trades on NASDAQ under the ticker QSI.

What do analysts say about Quantum-Si stock?

2 analysts rate the stock, the consensus is Buy (as of 29/09/2026).

The average price target is US$2.95, ranging from US$1.90 to US$4.00, with a median of US$2.95.

This is an external assessment, not a statement by Market Jury.

When does Quantum-Si report next?

The next earnings date is 04/11/2026.

Around past earnings, price swings were roughly 1% stronger than usual.

Does Quantum-Si pay a dividend?

No, Quantum-Si currently does not pay a dividend.

Which stocks are comparable to Quantum-Si?

Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.

How can I get Quantum-Si stock analyzed?

Clicking "Analyze stock" lets five strategies assess Quantum-Si against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.